Cassandra Marie Layman, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 175 Rim Dr, South Fork, PA 15956 Phone: 814-248-9358 |
News Archive
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Sports Authority, the nation's premier full-line sporting goods retailer, announced today that it has teamed up with the Melanoma Research Alliance (MRA) in recognition of May's Skin Cancer Awareness Month for the second year in a row.
As Americans continue to grapple with the novel coronavirus, one question is on a lot of people's minds: Are we already seeing, or will we eventually see, a second wave of the virus?
Researchers at UT Southwestern Medical Center have determined the specific way in which a destructive protein binds to and interferes with a molecule that removes low-density lipoproteins (LDL), the so-called "bad" cholesterol, from the blood.
› Verified 6 days ago